Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study
Clinical & Experimental Allergy · 2026
DOI: 10.1111/cea.70229 ↗At a glance
Multizentrische Studie in Clinical & Experimental Allergy, 2026. Written by Zhouxian Pan and 13 co-authors. Institution: Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for D…. Major MEDLINE topics: Desensitization, Immunologic, Rhinitis, Allergic, Pyroglyphidae, Antigens, Dermatophagoides. 28 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Beijing Natural Science Foundation, National Natural Science Foundation of China, Peking Union Medical College Hospital Talent Cultivation Program Category D.
Abstract (original language)
Background
In China, therapeutic options are limited by the narrow availability of allergen preparations, with house dust mite (HDM) allergen immunotherapy (AIT) as the main choice for most patients. However, polysensitization is highly prevalent, and the benefit of HDM AIT in such patients remains uncertain. The study aims to evaluate the effectiveness of single‐allergen HDM AIT on both perennial and coexisting allergen‐specific symptoms in polysensitised allergic rhinitis (AR) patients and to explore predictors of treatment response.
Methods
We performed a multicenter retrospective cohort study including 81 patients with AR who were polysensitised to HDM and at least one other inhalant allergen (e.g., pollens, mould or animal dander). All participants received HDM subcutaneous immunotherapy (SCIT) for 12 to 36 months. Baseline characteristics, including serum allergen‐specific IgE (sIgE) levels and comorbidities, were collected. Symptom severity was assessed using the Visual Analog Scale (VAS), and treatment response was defined as a ≥ 30% reduction in VAS scores from baseline. Statistical comparisons between responders and non‐responders were conducted using Fisher's exact test for categorical variables and Mann–Whitney U tests for continuous data. Firth logistic regression was used to identify predictors of treatment response.
Results
The overall response rate for perennial symptoms was 68.8%, and varied in patients with co‐existing allergies: 72.7% for moulds, 70.0% for animal dander, 65.5% for tree pollen, 70.2% for weed pollens. Allergen‐specific symptom response rates varied across allergens: 68.2% for moulds, 30.0% for animal dander, 56.7% for tree pollens, 74.5% for weed pollens. Higher sIgE levels to HDM and mould were significantly associated with lower response rates in patients co‐sensitised to both. A predictive model incorporating both sIgEs showed good specificity.
Conclusion
Single‐allergen HDM AIT is effective in many polysensitised AR patients; however, its efficacy varies by coexisting allergen type and sIgE level. Patients co‐sensitised to mould with high HDM and mould sIgE appeared to have poorer outcomes. These preliminary findings require confirmation in larger prospective studies to guide tailored AIT strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing, China.
- Eight-Year Medical Doctor Program, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Respiratory Medicine, General Hospital of the Northern Theater Command of the Chinese People's Liberation Army, Shenyang, China.
- Department of Allergy, Children's Hospital of the Capital Institute of Pediatrics, Beijing, China.
- Department of Respiratory Disease, Shenzhen Children's Hospital, Shenzhen, China.
ORCID profiles: Shengyang Yao, Yongshi Yang, Rongfei Zhu, Kai Guan
Funding
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Peking Union Medical College Hospital Talent Cultivation Program Category D
- Natural Science Foundation of Beijing Municipality
Cite
APA
Pan, Z., Yao, S., Li, L., Yang, Y., Guan, W., Wang, Y., Lou, X., Liu, C., Bao, Y., Zhuang, S., Sha, L., Chai, R., Zhu, R., & Guan, K. (2026). Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70229
Vancouver
Pan Z, Yao S, Li L, Yang Y, Guan W, Wang Y, et al. Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70229
BibTeX
@article{Pan2026,
author = {Pan, Zhouxian and Yao, Shengyang and Li, Lisha and Yang, Yongshi and Guan, Wenchao and Wang, Yin and Lou, Xiaoshang and Liu, Chuanhe and Bao, Yanmin and Zhuang, Shijie and Sha, Li and Chai, Ruonan and Zhu, Rongfei and Guan, Kai},
title = {Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study},
journal = {Clinical & Experimental Allergy},
year = {2026},
doi = {10.1111/cea.70229}
}
EUVIMED